
Yicun Wu
Examiner (ID: 5533, Phone: (571)272-4087 , Office: P/2153 )
| Most Active Art Unit | 2153 |
| Art Unit(s) | 2165, 2175, 2158, 2153, 2169 |
| Total Applications | 1032 |
| Issued Applications | 828 |
| Pending Applications | 62 |
| Abandoned Applications | 165 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9643197
[patent_doc_number] => 20140221308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'METHODS AND COMPOSITIONS OF REDUCING AND PREVENTING BACTERIAL GROWTH AND THE FORMATION OF BIOFILM ON A SURFACE UTILIZING CHITOSAN-DERIVATIVE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/130253
[patent_app_country] => US
[patent_app_date] => 2012-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 38443
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14130253
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/130253 | METHODS AND COMPOSITIONS OF REDUCING AND PREVENTING BACTERIAL GROWTH AND THE FORMATION OF BIOFILM ON A SURFACE UTILIZING CHITOSAN-DERIVATIVE COMPOUNDS | Jun 28, 2012 | Abandoned |
Array
(
[id] => 9575277
[patent_doc_number] => 08765692
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-01
[patent_title] => 'Modified-galactosyl ceramides for staining and stimulating natural killer T cells'
[patent_app_type] => utility
[patent_app_number] => 13/531124
[patent_app_country] => US
[patent_app_date] => 2012-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 8
[patent_no_of_words] => 11507
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13531124
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/531124 | Modified-galactosyl ceramides for staining and stimulating natural killer T cells | Jun 21, 2012 | Issued |
Array
(
[id] => 11059519
[patent_doc_number] => 20160256481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-08
[patent_title] => 'USE OF WATER SOLUBLE PLATINUM COMPLEX IN PREPARING DRUGS FOR PREVENTION AND TREATMENT OF CANCERS'
[patent_app_type] => utility
[patent_app_number] => 14/369715
[patent_app_country] => US
[patent_app_date] => 2012-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9736
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14369715
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/369715 | USE OF WATER SOLUBLE PLATINUM COMPLEX IN PREPARING DRUGS FOR PREVENTION AND TREATMENT OF CANCERS | Jun 21, 2012 | Abandoned |
Array
(
[id] => 9657310
[patent_doc_number] => 20140228315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'BLOCKADE OF EOSINOPHIL PRODUCTION BY TOLL-LIKE RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 14/126244
[patent_app_country] => US
[patent_app_date] => 2012-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 13844
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14126244
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/126244 | BLOCKADE OF EOSINOPHIL PRODUCTION BY TOLL-LIKE RECEPTORS | Jun 17, 2012 | Abandoned |
Array
(
[id] => 8431165
[patent_doc_number] => 20120253041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'NEW PHENYLALANINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/524318
[patent_app_country] => US
[patent_app_date] => 2012-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23678
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13524318
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/524318 | Phenylalanine derivatives | Jun 14, 2012 | Issued |
Array
(
[id] => 9699412
[patent_doc_number] => 20140249098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-04
[patent_title] => 'Pharmaceutical Composition Comprising Dapagliflozin and Cyclodextrin'
[patent_app_type] => utility
[patent_app_number] => 14/117167
[patent_app_country] => US
[patent_app_date] => 2012-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9153
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117167
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/117167 | Pharmaceutical composition comprising dapagliflozin and cyclodextrin | May 31, 2012 | Issued |
Array
(
[id] => 9422418
[patent_doc_number] => 20140107069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'PLANT TREATMENT METHOD'
[patent_app_type] => utility
[patent_app_number] => 14/119927
[patent_app_country] => US
[patent_app_date] => 2012-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9647
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14119927
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/119927 | PLANT TREATMENT METHOD | May 23, 2012 | Abandoned |
Array
(
[id] => 9617001
[patent_doc_number] => 20140206859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'PROCESS FOR THE PREPARATION OF COMPOUNDS USEFUL AS INHIBITORS OF SGLT-2'
[patent_app_type] => utility
[patent_app_number] => 14/118653
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23474
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118653
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/118653 | PROCESS FOR THE PREPARATION OF COMPOUNDS USEFUL AS INHIBITORS OF SGLT-2 | May 17, 2012 | Abandoned |
Array
(
[id] => 11331695
[patent_doc_number] => 09522931
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-20
[patent_title] => 'Process for the preparation of compounds useful as inhibitors of SGLT-2'
[patent_app_type] => utility
[patent_app_number] => 14/118643
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 28601
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118643
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/118643 | Process for the preparation of compounds useful as inhibitors of SGLT-2 | May 17, 2012 | Issued |
Array
(
[id] => 10920685
[patent_doc_number] => 20140323705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'MANUFACTURE OF LACTO-N-TETRAOSE'
[patent_app_type] => utility
[patent_app_number] => 14/117104
[patent_app_country] => US
[patent_app_date] => 2012-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21653
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117104
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/117104 | MANUFACTURE OF LACTO-N-TETRAOSE | May 13, 2012 | Abandoned |
Array
(
[id] => 11219209
[patent_doc_number] => 09447540
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-20
[patent_title] => 'Process for treating microfibrillated cellulose and microfibrillated cellulose treated according to the process'
[patent_app_type] => utility
[patent_app_number] => 14/116571
[patent_app_country] => US
[patent_app_date] => 2012-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3759
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116571
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/116571 | Process for treating microfibrillated cellulose and microfibrillated cellulose treated according to the process | May 10, 2012 | Issued |
Array
(
[id] => 8523351
[patent_doc_number] => 20120322759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'SEMULOPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN CANCER PATIENTS RECEIVING CHEMOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/469773
[patent_app_country] => US
[patent_app_date] => 2012-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10662
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13469773
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/469773 | SEMULOPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN CANCER PATIENTS RECEIVING CHEMOTHERAPY | May 10, 2012 | Abandoned |
Array
(
[id] => 9363901
[patent_doc_number] => 20140073774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => 'PROCESS FOR TREATING CELLULOSE AND CELLULOSE TREATED ACCORDING TO THE PROCESS'
[patent_app_type] => utility
[patent_app_number] => 14/116590
[patent_app_country] => US
[patent_app_date] => 2012-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5180
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116590
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/116590 | Process for treating cellulose and cellulose treated according to the process | May 10, 2012 | Issued |
Array
(
[id] => 9626765
[patent_doc_number] => 08796446
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-05
[patent_title] => 'Extraction of carboxylic acids with tin compounds'
[patent_app_type] => utility
[patent_app_number] => 13/463332
[patent_app_country] => US
[patent_app_date] => 2012-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8593
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13463332
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/463332 | Extraction of carboxylic acids with tin compounds | May 2, 2012 | Issued |
Array
(
[id] => 8417052
[patent_doc_number] => 20120244551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'PORPHYRINIC COMPOUNDS FOR USE IN FLOW CYTOMETRY'
[patent_app_type] => utility
[patent_app_number] => 13/459464
[patent_app_country] => US
[patent_app_date] => 2012-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 39991
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13459464
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/459464 | Porphyrinic compounds for use in flow cytometry | Apr 29, 2012 | Issued |
Array
(
[id] => 8483796
[patent_doc_number] => 20120283203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF OBESITY, INSULIN RELATED DISEASES AND HYPERCHOLESTEROLEMIA'
[patent_app_type] => utility
[patent_app_number] => 13/460781
[patent_app_country] => US
[patent_app_date] => 2012-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10439
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13460781
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/460781 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF OBESITY, INSULIN RELATED DISEASES AND HYPERCHOLESTEROLEMIA | Apr 29, 2012 | Abandoned |
Array
(
[id] => 9122342
[patent_doc_number] => 20130289265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'METHODS AND COMPOSITIONS FOR EXTRACTION AND STORAGE OF NUCLEIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 13/460076
[patent_app_country] => US
[patent_app_date] => 2012-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4751
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13460076
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/460076 | Methods and compositions for extraction and storage of nucleic acids | Apr 29, 2012 | Issued |
Array
(
[id] => 9295283
[patent_doc_number] => 20140038917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'STERILE AND INJECTABLE AQUEOUS FORMULATION FOR ADMINISTRATION IN THE INTRA-ARTICULAR SPACE OF AN INTRA-ARTICULAR JOINT'
[patent_app_type] => utility
[patent_app_number] => 14/112437
[patent_app_country] => US
[patent_app_date] => 2012-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4881
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112437
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112437 | STERILE AND INJECTABLE AQUEOUS FORMULATION FOR ADMINISTRATION IN THE INTRA-ARTICULAR SPACE OF AN INTRA-ARTICULAR JOINT | Apr 18, 2012 | Abandoned |
Array
(
[id] => 9384558
[patent_doc_number] => 20140088040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'COSMETIC SOLUTION, METHOD FOR PRODUCING COSMETIC SOLUTION, AND COSMETIC METHOD'
[patent_app_type] => utility
[patent_app_number] => 14/116594
[patent_app_country] => US
[patent_app_date] => 2012-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9717
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116594
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/116594 | Cosmetic solution, method for producing cosmetic solution, and cosmetic method | Apr 16, 2012 | Issued |
Array
(
[id] => 8417609
[patent_doc_number] => 20120245109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'ANTITHROMBOTIC DUAL INHIBITORS COMPRISING A BIOTIN RESIDUE'
[patent_app_type] => utility
[patent_app_number] => 13/438905
[patent_app_country] => US
[patent_app_date] => 2012-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7135
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13438905
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/438905 | Antithrombotic dual inhibitors comprising a biotin residue | Apr 3, 2012 | Issued |